Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: Diabetologia. 2009 Jul 25;52(10):2169–2181. doi: 10.1007/s00125-009-1451-3

Fig. 5.

Fig. 5

Expression in human myotubes of TACE (a), TIMP3 (b), TACE/TIMP3 ratio (c) and β-actin (d). *p<0.05, 200 µmol/l NEFA vs BSA control (BSA-Ctrl); **p<0.05, 400 µmol/l NEFA vs BSA. †p<0.05, 200 µmol/l NEFA vs 400 µmol/l NEFA. n=4–6 per group. Data are means ± SEM